Ocular Therapeutix (OCUL) is a Strong Buy, driven by the pivotal SOL-1 Phase 3 trial for AXPAXLI™ in wet AMD, with topline ...

Blindsight will enable those who have total loss of vision… to be able to see again,” tweeted Elon Musk. That’s not the kind ...

Cortigent is a leading developer of brain interface devices based on precision neurostimulation technology The company’s new ...

The burden of presbyopia and reading glasses drives patients to look for solutions.“There is a clear and growing patient demand for noninvasive, reversible options to manage presbyopia,” Behnaz ...

Apple's rumored plan to enter the smart glasses market by late 2026 is already reshaping the global AR optics supply chain, ...

Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...

AI is reshaping clinical practice in retinal imaging and workflow optimization, according to Priv.-Doz. Dr. med. Jan H.

Vivani Medical subsidiary Cortigent announced the results of a study evaluating its Orion visual cortical prosthesis system.

The grand inauguration of the new branch of Adittya Eye Clinic, known for its legacy of quality, compassion, and dedication in eye care, was held with enthusiasm on Monday, January 26, 2026, in ...

Nitinol has arrived in minimally invasive glaucoma surgery, making symptom management for the progressive eye disease safer and personalized.